12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Company News  |  Deals

Isis Pharmaceuticals, SQI Diagnostics deal

SQI will use its Ig Plex multiplexing immunogenicity technology to develop a multiplex anti-drug antibody assay for Isis. Ig Plex allows for simultaneous quantification of Ig isotype...

Read the full 115 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >